⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BBIO News
BridgeBio Pharma, Inc. Common Stock
BridgeBio to Present Primary Results from Phase 3 PROPEL 3 Trial of Oral Infigratinib for Children Living with Achondroplasia at ICCBH 2026
globenewswire.com
BBIO
GondolaBio Announces Positive Phase 2a Results Demonstrating 79% Plasma Protoporphyrin IX Reduction and Disease-Modifying Potential of PORT-77 for Erythropoietic Protoporphyria
businesswire.com
BBIO
Global Cell and Gene Therapy CDMO Market Anticipating Remarkable Growth at a CAGR of ~24% by 2034 | DelveInsight
globenewswire.com
TMO
CRL
BBIO
PTC
BMRA
BIIB
PFE
DKSH Enters Strategic Distribution Partnership with BridgeBio to Support Regulatory Evaluation and Potential Patient Access to Transthyretin Stabilizer for ATTR-CM in Selected Asia Pacific Markets
prnewswire.com
BBIO
Form 8-K
sec.gov
BBIO
BridgeBio Announces FDA Acceptance and Priority Review of NDA for BBP-418 for LGMD2I/R9
globenewswire.com
BBIO
Invisible No More: Low Awareness, Missed Diagnoses -- New Survey Sheds Light on ATTR-CM's Hidden Impact on Women
prnewswire.com
BBIO
Form 8-K
sec.gov
BBIO
Muscular Dystrophy Association Announces $100,000 Investment to Advance LGMD Care at Leading MDA Care Centers with BridgeBio
globenewswire.com
BBIO
Wall Street's Cardiac Bet: Where Diagnostics Meet the Money
prnewswire.com
BBIO
BMY
ARWR
AMGN